Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small …
Business Intelligence
Competitors · Subsidiaries · Locations · Network
This feature shows
the market relationships of Anebulo Pharmaceuticals, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices,
fabrics and competitors around the globe.
Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.
U.S. · Business Intelligence
The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.
Worldwide · Business Intelligence
The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.
Worldwide · Competitors Table
Sourced from FMP or manual.
| Competitor | Private? | Source | Accuracy | Country | City |
|---|---|---|---|---|---|
| Acrivon Therapeutics, Inc. Common Stock | FMP | High | United States | Watertown | |
| PMV Pharmaceuticals, Inc. | FMP | High | United States | Cranbury | |
| AnaptysBio, Inc. | FMP | High | United States | San Diego | |
| FMP | High | - | - | ||
| AN2 Therapeutics, Inc. | FMP | High | United States | Menlo Park | |
| Mineralys Therapeutics, Inc. | FMP | High | United States | Radnor |
Worldwide · Subsidiaries Table
Sourced from the SEC, through government awards and manual entries.
| Subsidiary | Private? | Country | City |
|---|---|---|---|
| - | - | - | - |